Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component

Purpose. Comparative analysis of the efficacy and safety of Blefarovit product in the complex therapy of chronical blepharoconjunctivitis and «dry eye» syndrome with a pronounced demodicosis component in patients, previously received standard treatment with or without short-term positive effect. Mat...

Full description

Saved in:
Bibliographic Details
Main Authors: D.Yu. Maychuk, А.О. Loshkareva
Format: Article
Language:Russian
Published: Publishing house "Ophthalmology" 2022-09-01
Series:Офтальмохирургия
Subjects:
Online Access:https://ophthalmosurgery.ru/index.php/ophthalmosurgery/article/view/369/414
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590534305120256
author D.Yu. Maychuk
А.О. Loshkareva
author_facet D.Yu. Maychuk
А.О. Loshkareva
author_sort D.Yu. Maychuk
collection DOAJ
description Purpose. Comparative analysis of the efficacy and safety of Blefarovit product in the complex therapy of chronical blepharoconjunctivitis and «dry eye» syndrome with a pronounced demodicosis component in patients, previously received standard treatment with or without short-term positive effect. Material and methods. The present study included 60 patients (120 eyes) with chronical blepharoconjunctivitis, «dry eye» syndrome and demodicosis component. The patients, involved in the study had pronounced thickening of the eyelid margin, scabs and «clutches» in the eyelashes, meibomeitis, hyperemia, follicular reaction of the tarsal and bulbar conjunctiva. This study was devoted to finding a new approach for the demodecosis component therapy, using staged eyelid hygiene technology with the multicomponent product Blefarovit. The purpose of this study was to estimate efficacy and safety in isolated Blefarovit usage (1st stage of therapy) and Blefarovit in the combination with anti-inflammatory and artificial tears therapy (2nd stage of therapy). Results. The results of the study were increasing of the TBUT test and decreasing the of Demodex Folliculorum number. Conclusion. The usage of Blefarovit product made possible to show significant decreasing in the severity of the demodectic component without increasing the toxico-allergic background.
format Article
id doaj-art-582aab1e9b74485fadafeb7c5c6c5af3
institution Kabale University
issn 0235-4160
2312-4970
language Russian
publishDate 2022-09-01
publisher Publishing house "Ophthalmology"
record_format Article
series Офтальмохирургия
spelling doaj-art-582aab1e9b74485fadafeb7c5c6c5af32025-01-23T12:34:55ZrusPublishing house "Ophthalmology"Офтальмохирургия0235-41602312-49702022-09-013414910.25276/0235-4160-2022-3-41-49Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis componentD.Yu. Maychuk0https://orcid.org/0000-0003-1674-4656А.О. Loshkareva1https://orcid.org/0000-0001-8829-7133Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian FederationFyodorov Eye Microsurgery Federal State Institution, Moscow, Russian FederationPurpose. Comparative analysis of the efficacy and safety of Blefarovit product in the complex therapy of chronical blepharoconjunctivitis and «dry eye» syndrome with a pronounced demodicosis component in patients, previously received standard treatment with or without short-term positive effect. Material and methods. The present study included 60 patients (120 eyes) with chronical blepharoconjunctivitis, «dry eye» syndrome and demodicosis component. The patients, involved in the study had pronounced thickening of the eyelid margin, scabs and «clutches» in the eyelashes, meibomeitis, hyperemia, follicular reaction of the tarsal and bulbar conjunctiva. This study was devoted to finding a new approach for the demodecosis component therapy, using staged eyelid hygiene technology with the multicomponent product Blefarovit. The purpose of this study was to estimate efficacy and safety in isolated Blefarovit usage (1st stage of therapy) and Blefarovit in the combination with anti-inflammatory and artificial tears therapy (2nd stage of therapy). Results. The results of the study were increasing of the TBUT test and decreasing the of Demodex Folliculorum number. Conclusion. The usage of Blefarovit product made possible to show significant decreasing in the severity of the demodectic component without increasing the toxico-allergic background.https://ophthalmosurgery.ru/index.php/ophthalmosurgery/article/view/369/414blepharitisconjunctivitis«dry eye» syndromemeibomian gland dysfunctioneyelid hygienedemodex
spellingShingle D.Yu. Maychuk
А.О. Loshkareva
Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
Офтальмохирургия
blepharitis
conjunctivitis
«dry eye» syndrome
meibomian gland dysfunction
eyelid hygiene
demodex
title Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
title_full Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
title_fullStr Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
title_full_unstemmed Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
title_short Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
title_sort effectiveness and safety of blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and dry eye syndrome combined with an active demodicosis component
topic blepharitis
conjunctivitis
«dry eye» syndrome
meibomian gland dysfunction
eyelid hygiene
demodex
url https://ophthalmosurgery.ru/index.php/ophthalmosurgery/article/view/369/414
work_keys_str_mv AT dyumaychuk effectivenessandsafetyofblefarovitcosmeticproductusageinpatientswithchronicblepharoconjunctivitisanddryeyesyndromecombinedwithanactivedemodicosiscomponent
AT aoloshkareva effectivenessandsafetyofblefarovitcosmeticproductusageinpatientswithchronicblepharoconjunctivitisanddryeyesyndromecombinedwithanactivedemodicosiscomponent